长期COVID和后急性COVID-19疫苗接种综合征的重叠临床表现:表型,严重程度和生物标志物
Lawrence Purpura1,2, Thomas Heisler1,3, Steven Palmer1
1Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
概括
后急性COVID-19连续症 (PASC) 和后急性COVID-19疫苗接种综合症 (PACVS) 具有共同的症状,但在生物标志物上有所不同. PACVS显示出明显的自身抗体概况,表明自身免疫参与和针对性治疗的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 神经学 神经学
背景情况:
- 后急性COVID-19 (PASC) 或长期COVID和后急性COVID-19疫苗接种综合征 (PACVS) 的后急性后续症状存在重叠的临床挑战.
- 这项研究假设PASC和PACVS之间有共同的特征,但有不同的症状模式和生物标志物概况.
研究的目的:
- 为了确定PASC和PACVS之间临床表现的差异.
- 区分与临床实践相关的免疫生物标志物.
主要方法:
- 一项对来自PASC诊所的181名患者进行的横截面研究.
- 患者被分类为患有肌痛性脑筋炎/慢性疲劳综合征 (MECFS) 的PASC,没有MECFS的PASC (LC) 和PACVS组.
- 跨组症状流行/严重程度和免疫学异常的比较.
主要成果:
- 在所有组中,疲劳是最常见的症状.
- PACVS组报告了较高的外围神经病变,耳和皮疹的发生率.
- 与LC组相比,PACVS组显示出显著更高的抗心素IgM和抗U1-RNP阳性.
结论:
- PASC和PACVS的症状重叠,但具有不同的生物标志物模式,特别是PACVS的自身抗体升高.
- 研究结果表明,自免疫系统参与PACVS,需要进一步研究.
- 这些见解可以指导开发针对PASC和PACVS的向疗法.
关键词:
这是自身免疫力.长时间的COVID.肌痛性脑筋炎/慢性疲劳综合征 (ME-CFS) 的情况后急性COVID-19疫苗接种综合征 (PACVS) 是一种疾病.在COVID-19 (PASC) 的后急性后果中.更多相关视频
相关概念视频
COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
347
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
347
Myocarditis II: Clinical Features and Diagnostic Tests
258
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
258
Endocarditis II: Clinical Features of Infective Endocarditis
405
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
405
Vaccinations
51.2K
Overview
51.2K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
473
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
473


